articleJNCI Journal of the National Cancer InstituteSep 17, 2009Closed access

Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study

Taichung Veterans General Hospital · Taipei Veterans General Hospital · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Background

Hepatitis B virus (HBV) infection is a major cause of hepatocellular carcinoma. This population-based study aimed to investigate whether prevention of hepatocellular carcinoma by the universal Taiwanese HBV vaccine program, launched in July 1984, has extended beyond childhood and to identify the predictors of hepatocellular carcinoma for vaccinated birth cohorts.

Methods

Data on 1958 patients with hepatocellular carcinoma who were aged 6-29 years at diagnosis in Taiwan between 1983 and 2004 were collected from two national hepatocellular carcinoma registries. Age- and sex-specific incidence among vaccinated and unvaccinated birth cohorts were analyzed by using Poisson regression models. All statistical tests were two-sided. Records of 64 hepatocellular carcinoma patients and 5 524 435 HBV vaccinees who were born after the initiation of the vaccination program were compared for HBV immunization characteristics during infancy and prenatal maternal hepatitis B surface antigen (HBsAg) and e antigen (HBeAg) serostatus.

Citation impact

618
total citations
FWCI
28.02
Percentile
100%
References
28
Citations per year

Authors

12

Topics & keywords

Keywords
  • Hepatocellular carcinoma
  • Incidence (geometry)
  • Medicine
  • Virology
  • Internal medicine
  • Gastroenterology
  • Physics
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.